Developping innovative in-vitro kits for the ADME-Tox segment
What We Do
We develop, implement and commercialize cell-based ready-to-use kits that provide reliable results reducing time and costs. Pharmaceutical and biotech companies can use human and material resources more efficiently, while optimizing the development cycle for new drugs.
Our R&D department works on the expansion of our product portfolio, with the aim of developing new tools that fulfill the needs of the pharmaceutical industry. By offering a diversity of R&D service, we offer our expertise, know-how, technical & human resources to develop ad-hoc solutions.
Utilizamos cookies para asegurar que damos la mejor experiencia al usuario en nuestra web. Si sigues utilizando este sitio asumiremos que estás de acuerdo.Vale